Introduction
Protein kinase C (PKC) is a family of phospholipiddependent serine-threonine kinases that regulate cell growth and differentiation (reviewed in [ 1 4 ) . PKC is also the major intracellular receptor for tumour-promoting phorbol esters [ 1-31. Molecular cloning and biochemical separation of the individual gene products has led to a classification system for the PKC isoenzymes based on domain homology and biochemical properties. Conventional PKCs (a, PI, PI,, y ) [4, 5] . The fact that several agonists including platelet-derived growth factor [6, 7] , bombesin [7] , endothelin-l[8], phenylephrine [8] and oleic acid [9] can selectively activate novel PKCs 6 and/or E in vivo supports the hypothesis that isoenzyme-specific responses may be mediated in part by different signal transduction pathways.
In principle, the phosphorylation of different substrate proteins by individual isoenzymes should lead to distinct cellular responses. At present, little is known about isoenzyme substrate specificity in vivo. In vitro, phosphorylation of 'real' physiological substrates by different PKCs is similar [lo] . The fact that isoenzyme-specific substrate interactions are difficult to demonstrate in assays in vitro suggests that isoenzyme specificity may be dictated by interactions with other proteins and/or other Abbreviations used: CSK, cytoskeleton; MAP, microtubule-associated protein; MARCKS, myristoylated alanine-rich C-kinase substrate; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; PS, phosphatidylserine. $To whom correspondence is to be addressed.
factors. The purpose of this article is to focus on work that suggests that targeting PKC to different locations within the cell may be a determinant of isoenzyme-specific function in vivo.
Differential localization
Targeting PKCs to discrete subcellular compartments would restrict access to potential substrates. In this way, protein targeting coupled with isoenzyme-selective activation signals could determine isoenzyme-specific phosphorylations and consequently isoenzyme-specific responses. . These studies suggest that PS provides a bridge between the proteins, but additional protein-protein interactions confer stability on the ternary complex. Two lines of evidence suggest that the proteins detected with the overlay assay are of biological significance: first, several of the binding proteins in REF52 cells appear to be transformation sensitive [22-241, and secondly, several of the PKC-binding proteins are also substrates [24] . In fact, the major PKC substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), is also a PKC-binding protein [24] . PKC binding to MARCKS is modulated by the phosphorylation state of MARCKS [24] .
The fact that the PKC-binding proteins detected with the overlay assay are also substrates underscores the utility of this approach for identifying downstream targets of PKC action. Additional PKC binding proteinlsubstrates were identified by adapting the overlay assay for screening Agtll expression libraries [ 171. Interaction cloning yielded 11 clones: 5 known sequences and 6 unique clones.
The best characterized of these clones are: 35A, a rat homologue of MARCKS-related protein; 35H, a novel member of the adducin family; and 35F, a novel spice-variant of kinesin light chain [ 17,181. All of the binding proteins identified by interaction cloning are CSK-associated, PS-binding proteins that are also PKC substrates ([17,18] and S. Jaken, unpublished work) . Proteins with these characteristics are ideally suited to targeting PKC isoenzymes to discrete intracellular sites. Work is in progress to determine whether the PKC-binding sequences within these proteins can, in fact, target PKCs to different subcellular locations.
Differential localization studies in U937 cells 
Altered localization: altered phenotype
Changes in the expression of downstream targets could have profound effects on PKC signalling and localization; i.e. a loss of downstream targets could effectively abrogate a PKC-mediated pathway and result in an altered phenotype. In normal REF52 fibroblasts, PKC a is concentrated in the CSK at sites of cell-substratum adhesion, known as focal contacts [ZO] . SV40-transformation causes a change in PKC a localization that correlates with the loss of two major binding proteins [23] . In other studies with temperature-sensitive SV40-transformed REF52 fibroblasts, PKC a is not found in focal adhesions at the permissive temperature, but accumulates in the focal contacts 4-5 h after the switch to the non-permissive temperature for functional T-antigen expression [26] . 35H, a novel form of adducin identified by interaction cloning [ 171, is localized in the cell borders of normal rat proximal tubule epithelial (RPTE) cells and adenovirus E l Aimmortalized RPTE ([21] and S. Jaken, unpublished work) . PKC a co-localizes with 35H in both normal and immortalized RPTE cells [21] . However, when cells are transformed with SV40, both proteins are coordinately lost from cell borders (S. Jaken, unpublished work) . Similarly, the loss of PKC BzCs staining along microtubules in differentiated U937 cells correlates with the loss of MAPbinding proteins in the PKC overlay assay [13] . Taken together these results suggest a strong correlation between changes in both PKC and PKCbinding protein/substrate localization and alterations in phenotype.
Cellular differentiation is a complex process involving the co-ordinate up-regulation of some genes and the down-modulation of others. Phorbol ester-resistant HL60 cell variants, deficient in PKC B, have been used to demonstrate that this isoenzyme is required for macrophage differentiation [27-291. The fact that these cells were not growth inhibited and did not express B,-integrin adhesion molecules on the cell surface when treated with phorbol ester suggests that PKC mediates an early event in the differentiation process [27-291. PMA-resistant U937 cells (cloned by S.K.) differ from the HMO variants in several respects. First, all the PKC isoenzymes expressed in wild-type U937s are also expressed at comparable levels in the resistant cells (S. C. Kiley, R. Whelan, P. Adams and P. J. Parker, unpublished work). Secondly, the isoenzymes are activated and down-modulated by PMA to the same extent as in wild-type cells (S. C. Kiley, R. Whelan, P. Adams and P. J. Parker, unpublished work). Thirdly, despite the fact that PMA does not induce surface expression of &integrins or superoxide production in these cells, expression of p47Ph"" (one of the cytoplasmic components of the phagocyte NADPH oxidase) is induced (S. C. Kiley, R. Whelan, P. Adams Parker, unpublished work). These studies emphasize that PKC co-localization with CSK proteins may be indicative of a functional association between them, and that coordinate changes in PKC localization and binding protein/substrate expression may result in an altered phenotype.
Conclusion
Although much of the work reviewed here is correlative in nature, all of these studies point to the same conclusion; i.e. PKCs do not float freely in the cytoplasm or inner leaflet of the plasma membrane, but are targeted to different subcellular locations via interactions with other proteins. In situations where the targeting protein is also a PKC substrate, coordinate changes in the expression and localization of PKC and its substrate have functional consequences that may be manifested in an altered phenotype. As targeting proteins are identified by interaction cloning [17] or by yeast two-hybrid B and isoforms respectively [ S ] . 
